Live Webinar | Operations and Other Technology
Save
Live Webinar | Operations and Other Technology
Save
Live Webinar | Patient Financial Communications
Save
Comment Letter | Payment Reimbursement and Managed Care

HFMA Comments on Most Favored Nation (MFN) Model Interim Final Rule

Comment Letter | Payment Reimbursement and Managed Care

HFMA Comments on Most Favored Nation (MFN) Model Interim Final Rule

In a comment letter to CMS regarding the Most Favored Nation (MFN) Model Interim Final Rule (IFC), published in the Federal Register on November 27, 2020, HFMA noted that its members request that CMS withdraw the MFN Model immediately and begin a process of working with impacted stakeholders to develop and propose a payment model pilot that will actually address this root cause of unchecked inflation in  drug costs – manufacturer prices. HFMA believes any model that addresses manufacturer prices should not just address separately payable Part B drugs, but all drugs covered by Medicare Parts A, B, C and D. The letter addresses key concerns of HFMA’s members in detail. Specific concerns about the MFN Model IFC addressed in the letter include its:

  • Adverse Impact to Medicare Beneficiaries and Providers Who Administer High Volumes of MFN Covered Drugs
  • Misappropriation of the Center for Medicare & Medicaid Innovation’s (CMMI’s) Writ Subvert Congress’s Authority and Implement a National Payment Cut for Selected Separately Payable Par B Drugs
  • Failure to Give Stakeholders an Adequate Notice and Opportunity to Comment as Required by the Administrative Procedures Act (APA)
  • Scope and Timing

Download the comment letter

Sign up for a free guest account and get access to five free articles every month.

Advertisements

Related Articles | Payment Reimbursement and Managed Care

Fact Sheet | Payment Reimbursement and Managed Care

Health-Related Provisions of Inflation Reduction Act of 2022 Summary

HFMA presents a detailed summary of the health-related provisions of the new Inflation Reduction Act of 2022, signed by President Biden on August 16, 2022.

Fact Sheet | Payment Reimbursement and Managed Care

FY 2023 Medicare Inpatient Rehabilitation Facility Prospective Payment System Final Rule Summary

HFMA presents a detailed summary of the final rule pertaining to the Medicare inpatient rehabilitation facility prospective payment system for FY 2023.

Fact Sheet | Payment Reimbursement and Managed Care

CY 2023 OPPS/ASC Proposed Rule Summary

HFMA presents a detailed summary of the CY 2023 outpatient prospective payment system and ambulatory surgical center payment system proposed rule, published by CMS.

Fact Sheet | Payment Reimbursement and Managed Care

Conditions of Participation (CoPs) for Rural Emergency Hospitals and Critical Access Hospital CoP Updates Proposed Rule Summary

HFMA provides a detailed summary of the proposed rule establishing Rural Emergency Hospital Conditions of Participation (CoPs), and also changes to the Critical Access Hospital CoPs.